145 related articles for article (PubMed ID: 1427504)
1. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Chan VS; Caldwell J
Food Chem Toxicol; 1992 Oct; 30(10):831-6. PubMed ID: 1427504
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of the alkenylbenzenes alpha- and beta-asarone, myristicin and elimicin as determined by the UDS assay in cultured rat hepatocytes.
Hasheminejad G; Caldwell J
Food Chem Toxicol; 1994 Mar; 32(3):223-31. PubMed ID: 8157216
[TBL] [Abstract][Full Text] [Related]
3. Structure-specificity of the genotoxicity of some naturally occurring alkenylbenzenes determined by the unscheduled DNA synthesis assay in rat hepatocytes.
Howes AJ; Chan VS; Caldwell J
Food Chem Toxicol; 1990 Aug; 28(8):537-42. PubMed ID: 2242826
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
[TBL] [Abstract][Full Text] [Related]
5. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
Swanson AB; Miller EC; Miller JA
Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
[TBL] [Abstract][Full Text] [Related]
6. Structure-genotoxicity relationships of allylbenzenes and propenylbenzenes: a quantum chemical study.
Tsai RS; Carrupt PA; Testa B; Caldwell J
Chem Res Toxicol; 1994; 7(1):73-6. PubMed ID: 8155828
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and genotoxicity of methyleugenol and related congeners-- a mechanism of activation for methyleugenol.
Burkey JL; Sauer JM; McQueen CA; Sipes IG
Mutat Res; 2000 Sep; 453(1):25-33. PubMed ID: 11006409
[TBL] [Abstract][Full Text] [Related]
9. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
Randerath K; Haglund RE; Phillips DH; Reddy MV
Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
[TBL] [Abstract][Full Text] [Related]
11. DNA adducts derived from safrole, estragole and related compounds, and from benzene and its metabolites.
Phillips DH
IARC Sci Publ; 1994; (125):131-40. PubMed ID: 7806308
[No Abstract] [Full Text] [Related]
12. DNA adducts from alkoxyallylbenzene herb and spice constituents in cultured human (HepG2) cells.
Zhou GD; Moorthy B; Bi J; Donnelly KC; Randerath K
Environ Mol Mutagen; 2007 Dec; 48(9):715-21. PubMed ID: 17948277
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
[TBL] [Abstract][Full Text] [Related]
14. The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants.
Swanson AB; Chambliss DD; Blomquist JC; Miller EC; Miller JA
Mutat Res; 1979 Apr; 60(2):143-53. PubMed ID: 379623
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the role of the 2',3'-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs.
Guenthner TM; Luo G
Toxicology; 2001 Mar; 160(1-3):47-58. PubMed ID: 11246123
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical identification of hepatic protein adducts derived from estragole.
Wakazono H; Gardner I; Eliasson E; Coughtrie MW; Kenna JG; Caldwell J
Chem Res Toxicol; 1998 Aug; 11(8):863-72. PubMed ID: 9705747
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of allylbenzene analogues in vivo and in vitro through the epoxide-diol pathway.
Delaforge M; Janiaud P; Levi P; Morizot JP
Xenobiotica; 1980 Oct; 10(10):737-44. PubMed ID: 7456490
[TBL] [Abstract][Full Text] [Related]
18. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice.
Phillips DH; Reddy MV; Randerath K
Carcinogenesis; 1984 Dec; 5(12):1623-8. PubMed ID: 6499113
[TBL] [Abstract][Full Text] [Related]
19. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole.
Miller JA; Miller EC
Br J Cancer; 1983 Jul; 48(1):1-15. PubMed ID: 6191767
[TBL] [Abstract][Full Text] [Related]
20. Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning.
Auerbach SS; Shah RR; Mav D; Smith CS; Walker NJ; Vallant MK; Boorman GA; Irwin RD
Toxicol Appl Pharmacol; 2010 Mar; 243(3):300-14. PubMed ID: 20004213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
